The following is a summary of “Expert consensus on the benefits of neuraminidase in conventional influenza vaccines: a Delphi study,” published in the January 2025 issue of Infectious Disease by ...
The first inactivated influenza vaccine was monovalent (influenza ... The subtype [16 possible hemagglutinin and 9 possible neuraminidase subtypes]. Thus, a type A virus isolated in 1995 in ...
Current vaccines work by stimulating the immune ... in the influenza virus’s surface proteins (like hemagglutinin and neuraminidase), allowing it to evade immune recognition over time.
24, 2025 — A therapeutic vaccine targeting human papillomavirus type 16 (HPV16) induced regression in high-grade precancerous cervical lesions, according to the results from a phase II clinical ...
There is no antiviral treatment for the miserable but thankfully short-lived illness, and no vaccine—yet. But scientists at Moderna are in the late stages of testing what could be the first such ...